Related Experiment Video
Updated: Aug 8, 2026

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
[Mycoplasma infections]
1Servicio de Medina Interna e Infecciones, Hospital General de Castellón, Universidad de Valencia. brocav@meditex.es
Abstract:
Mycoplasmas are prokaryote microorganisms without cellular wall, that usually colonize the respiratory and urogenital mucosae. The pathogenic species for mankind are Mycoplasma pneumoniae, that produce respiratory infections, among them pneumonia, and M. genitalium, M. hominis and Ureaplasma urealyticum, that produce urinary and genital infections. The diagnosis of these infections is fundamentally based on serology, since the culture of these germs is very laborious. In a near future, the antigen or DNA detection molecular techniques will probably permit a much faster and reliable diagnosis. The tetracyclines and fluorquinolones have excellent activity against these microorganisms.
Insights
Mycoplasmas, bacteria lacking cell walls, cause respiratory and urogenital infections. Future molecular diagnostics and current antibiotics like tetracyclines offer better management of these common human pathogens.
Area of Science:
- Microbiology
- Infectious Diseases
Context:
- Mycoplasmas are wall-less prokaryotes colonizing mucosal surfaces.
- Pathogenic species Mycoplasma pneumoniae, M. genitalium, M. hominis, and Ureaplasma urealyticum cause significant human infections.
Purpose:
- To review the characteristics, diagnosis, and treatment of Mycoplasma and Ureaplasma infections.
- To highlight the limitations of current diagnostic methods and the potential of emerging molecular techniques.
Summary:
- Mycoplasma pneumoniae causes respiratory illnesses, while M. genitalium, M. hominis, and Ureaplasma urealyticum are linked to genitourinary infections.
- Current diagnosis relies heavily on serology, which is time-consuming.
- Tetracyclines and fluoroquinolones demonstrate potent antimicrobial activity against these organisms.
Impact:
- Improved diagnostic strategies, including molecular methods, are anticipated to enhance patient outcomes.
- Understanding Mycoplasma and Ureaplasma infections is crucial for effective clinical management and public health.
- Antimicrobial susceptibility data guides the selection of effective treatments, such as tetracyclines and fluoroquinolones.
Related Concept Videos
Atypical Pneumonia
Bacterial Phylum Tenericutes
Trichomoniasis
Bacterial Phylum Chlamydiae
Sexually Transmitted Infections
Toxoplasmosis